The Securities and Exchange Commission has signaled a definitive return to empirical rigor and analytical precision with the appointment of Dr. Joshua T. White as Chief Economist and Director of the Division of Economic and Risk Analysis. Scheduled to assume his leadership role during the week of January 5, 2026, Dr. White arrives at a pivotal juncture for the Commission as it seeks to fortify its regulatory framework through the integration of sophisticated data analytics and financial economics. This transition marks the conclusion of Robert Fisher’s tenure as Acting Chief Economist, a role he has held since January. Mr. Fisher will continue to serve the agency within the division, providing essential continuity and support for its multifaceted mission.
The selection of Dr. White underscores a strategic shift under Chairman Paul S. Atkins, who has prioritized the restoration of quantitative discipline in the agency’s rulemaking processes. By emphasizing the necessity of reliably quantifying the potential costs and benefits of any proposed rule, the Commission is signaling a commitment to a more transparent and economically defensible regulatory environment. Dr. White is recognized as a distinguished researcher and a proponent of high-quality economic analysis, with specialized expertise in financial regulation and the evolving cryptocurrency landscape. His appointment is viewed as an institutional effort to ensure that the Commission’s policy decisions are grounded in unbiased, evidence-based research that can withstand the scrutiny of the broader financial community and the judiciary.
Dr. White’s professional trajectory illustrates a profound familiarity with the internal mechanisms of the agency. Between 2012 and 2018, he served in several key capacities within the division he is now set to lead, including roles as a financial economist, visiting academic scholar, and expert consultant. During this period, his work focused on the critical cost-benefit assessments that are fundamental to modern securities regulation. For the past eighteen months, Dr. White has been on leave from his academic post as an assistant professor of finance at Vanderbilt University’s Owen Graduate School of Management to serve at the Public Company Accounting Oversight Board. His tenure at the board, where he functioned as a senior advisor before becoming acting chief economist this past April, has further refined his ability to bridge the gap between complex academic theory and practical regulatory oversight.
Beyond his regulatory and advisory experience, Dr. White’s academic pedigree provides a foundation of intellectual authority. Prior to his faculty appointment at Vanderbilt, he served as an assistant professor of finance at the University of Georgia’s Terry College of Business. His extensive research in corporate finance and governance has reached a global audience through publications in the industry’s most prestigious peer-reviewed journals, including the Journal of Financial Economics, the Review of Financial Studies, and The Accounting Review. This scholarly depth is expected to enhance the robustness of the division’s output, providing the SEC with the intellectual capital required to navigate increasingly complex global markets.
Ultimately, the return of Dr. White to the Commission reflects a broader mandate to enhance market confidence through rigorous inquiry. An alumnus of the University of Tennessee’s Haslam College of Business, where he earned his BS, MBA, and Ph.D. in finance, Dr. White has consistently been recognized for his contributions to the field, including receiving the Outstanding Ph.D. Alumnus Award. As he prepares to lead the division’s talented roster of economists, his stated mission is to utilize a diverse range of research perspectives to strengthen the analytical foundations of the Commission. By fostering a culture of thorough and unbiased economic evaluation, the agency aims to ensure that its regulatory interventions are both effective and conducive to the long-term health of the capital markets.
Announcement